<?xml version="1.0" encoding="UTF-8"?>
<ref id="B5-pharmaceutics-11-00234" class="ref">
 <label class="label">5.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Pinna</surname>
    <given-names class="given-names">R.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Campus</surname>
    <given-names class="given-names">G.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Cumbo</surname>
    <given-names class="given-names">E.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Mura</surname>
    <given-names class="given-names">I.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Milia</surname>
    <given-names class="given-names">E.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Xerostomia induced by radiotherapy: An overview of the physiopathology, clinical evidence, and management of the oral damage</article-title>
  <source class="source">Ther. Clin. Risk Manag.</source>
  <year class="year">2015</year>
  <volume class="volume">11</volume>
  <fpage class="fpage">171</fpage>
  <lpage class="lpage">188</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.2147/TCRM.S70652</pub-id>
  <?supplied-pmid 25691810?>
  <pub-id pub-id-type="pmid" class="pub-id">25691810</pub-id>
 </element-citation>
</ref>
